With early detection, 5-year survival rates for ovarian cancer exceed 90%, yet no effective early
screening method exists. Emerging consensus suggests over 50% of the most lethal form …

In swine models, there are well-established protocols for creating a closed-chest myocardial
infarction (MI) as well as protocols for characterization of cardiac function with cardiac …

Background. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
are under preclinical investigation as a cell-based therapy for heart failure post-myocardial …

… Jen Watson Koevary Jen Watson Koevary … Lancaster, Koevary, and Goldman have a
financial interest in Avery Therapeutics, a biotechnology company that is commercializing platform …

This review will outline cell-based therapy for heart failure focusing on tissue engineering to
deliver cells to the damaged heart. We will present an overview of the central approaches …

This perspective focuses on the development of tissue engineered (TE) cell-based therapies
to treat left ventricular (LV) dysfunction and chronic heart failure (CHF). The development of …

Patients diagnosed with heart failure with reduced ejection fraction (HFrEF) are at increased
risk of monomorphic ventricular tachycardia (VT) and ventricular fibrillation. The presence of …

Background. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
are under preclinical investigation as a cell-based therapy for heart failure post-myocardial …

Background: Worldwide, the prevalence of heart failure (HF) is increasing and HF patients
are living longer. Chronic ischemic HF presents with increased vulnerability to ventricular …

A recent report demonstrated that a laboratory-grown neobladder tissue could be successfully
used for cystoplasty in young patients with myelomeningocele who were otherwise healthy…